Northern Trust Company of Connecticut’s AbbVie ABBV Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$30.2M	Buy	572,490 +35,616	+7%	+$1.75M	0.19%	121
2013 Q3	$24M	Buy	536,874 +74,092	+16%	+$3.28M	0.16%	170
2013 Q2	$19.1M	Buy	+462,782	New	+$20.2M	0.13%	207

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Company of Connecticut's ABBV Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its AbbVie (ABBV) stake by 6.6% in Q4 2013, buying an estimated $1.75M and bringing the position to 572,490 shares worth $30.2M. The position accounts for 0.19% of the portfolio, ranked #121.

Northern Trust Company of Connecticut first reported a position in ABBV in Q2 2013 and has held it in 3 quarters since. 1,435 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

Northern Trust Company of Connecticut held 572,490 shares of AbbVie worth $30.2M as of Q4 2013.
Northern Trust Company of Connecticut bought 35,616 AbbVie shares in Q4 2013, an estimated $1.75M.
AbbVie made up 0.19% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #121 holding.
Northern Trust Company of Connecticut first reported a position in AbbVie in Q2 2013 and has held it in 3 quarters since.
1,435 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.